Document is current
Any future updates will be listed below
-
Authors
Chen, Alice P.
Kummar, Shivaani
Rubinstein, Larry
Zlott, Jennifer
Coyne, Geraldine O’Sullivan
Chung, Vincent
Newman, Edward M.
Lenz, Heinz-Josef
Kelly, Karen
Villaruz, Liza C.
Konaté, Mariam M.
Ferry-Galow, Katherine V.
Wang, Lihua
Kinders, Robert J.
Parchment, Ralph E.
Covey, Joseph M.
Holleran, Julianne L.
Piekarz, Richard L.
Miller, Sarah B.
Juwara, Lamin
Beumer, Jan H.
Doroshow, James H.
-
Funding
Funding for this research was provided by:
National Cancer Institute
- License Information
-
More Information
Article History
Received: 24 July 2025
Accepted: 29 October 2025
First Online: 22 December 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the National Institutes of Health and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Shivaani Kummar: Consultant/Advisory board: Springworks Therapeutics, SeaGen, Bayer, Genome & Company, HarbourBiomed, BPGbio Therapeutics, Oxford Biotherapeutics, Mundibiopharma, BPGbio, Inc., Gilead, Mirati; GI Innovation Inc, XYone Therapeutics, Genome Insight, Aadi Biosciences, MOMA Therapeutics, Daiichi Sankyo, Parabilis, Boehringer Ingelheim Pharmaceuticals, PATHOMIQ (co-founder), Fortress Biotech, Inc (equity), Sift Biosciences (equity). All other authors declare that they have no competing interests.
